BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 23447486)

  • 21. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
    Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Lymph Node Density With Negative Outcome Predictors in Oral and Maxillofacial Squamous Cell Carcinoma.
    Kim RY; Ward BB; Brockhoff HC; Helman JI; Braun TM; Skouteris CA
    J Oral Maxillofac Surg; 2016 Oct; 74(10):2081-4. PubMed ID: 27102923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic impact of lymph-node dissection on lobectomy for pulmonary metastasis.
    Shiono S; Matsutani N; Okumura S; Nakajima J; Horio H; Kohno M; Ikeda N; Kawamura M;
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):616-21; discussion 621. PubMed ID: 25605827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues.
    Yilmaz M; Karatas OF; Yuceturk B; Dag H; Yener M; Ozen M
    Head Neck; 2015 Sep; 37(9):1344-8. PubMed ID: 24817638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    Haisma MS; Plaat BEC; Bijl HP; Roodenburg JLN; Diercks GFH; Romeijn TR; Terra JB
    J Am Acad Dermatol; 2016 Oct; 75(4):722-730. PubMed ID: 27473455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome and prognostic factors after salvage surgery for isolated regional squamous cell carcinoma recurrences.
    Chung EJ; Lee SH; Baek SH; Bae WJ; Chang YJ; Rho YS
    Head Neck; 2015 Nov; 37(11):1612-7. PubMed ID: 24931743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
    Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
    J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
    Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
    Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx.
    Brasilino de Carvalho M
    Head Neck; 1998 Jan; 20(1):16-21. PubMed ID: 9464947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
    Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node density as an independent predictor of cancer-specific mortality in patients with lymph node-positive laryngeal squamous cell carcinoma after laryngectomy.
    Ryu IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    Head Neck; 2015 Sep; 37(9):1319-25. PubMed ID: 24828891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of HAX-1 expression in laryngeal carcinoma.
    You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
    Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
    Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
    Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
    Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.